Vivos Therapeutics
VVOS
VVOS
20 hedge funds and large institutions have $802K invested in Vivos Therapeutics in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
60% less capital invested
Capital invested by funds: $2M → $802K (-$1.2M)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$111K | |
| 2 | +$91.4K | |
| 3 | +$51K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$35.7K |
Top Sellers
| 1 | -$1.04M | |
| 2 | -$429K | |
| 3 | -$1.12K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$691 |
| 5 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$51 |